<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> results in a selective destruction of cell bodies within the hippocampus and cortex </plain></SENT>
<SENT sid="1" pm="."><plain>This cellular destruction appears to be mediated through a release of endogenous exictatory amino acids following the ischemic episode, since the neurotoxic effects of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> can be attenuated by compounds that have <z:chebi fb="68" ids="48706">antagonist</z:chebi> activity at <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptors </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, the protective effects of a novel <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, CGS 19755, were further evaluated by using quantitative autoradiography to characterize <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1, <z:chebi fb="0" ids="31882">NMDA</z:chebi>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>, and <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi> receptors in ischemic gerbil brain </plain></SENT>
<SENT sid="3" pm="."><plain>Bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (20 minutes) resulted in marked decreases (30-60%) in <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1, <z:chebi fb="0" ids="31882">NMDA</z:chebi>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>, but not <z:chebi fb="13" ids="22720">benzodiazepine</z:chebi>, receptors in gerbil forebrain </plain></SENT>
<SENT sid="4" pm="."><plain>Postischemic treatment with CGS 19755 was found to completely block the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced decreases in brain <z:chebi fb="3" ids="16335">adenosine</z:chebi> and <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="5" pm="."><plain>[3H]TCP binding in ischemic gerbil brain was also elevated by CGS 19755 treatment; significant differences remained, however, between the CGS 19755-treated and control gerbils </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate that transient <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> produces significant and selective alterations in gerbil forebrain receptor systems </plain></SENT>
<SENT sid="7" pm="."><plain>The observed decreases in radioligand binding are probably reflective of an <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced destruction of forebrain structures </plain></SENT>
<SENT sid="8" pm="."><plain>However, there is some evidence that <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> can also cause long-term changes in the affinity of some receptor systems </plain></SENT>
<SENT sid="9" pm="."><plain>The postischemic efficacy of CGS 19755 appears to be due to its ability to block the neurotoxic effects of <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
</text></document>